{"transactions":[{"id":4627623,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-28T20:24:42.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning September 24, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four year period."}],"balance_after":360000,"derivative":{"exercise_price":1.74,"expiration_date":"2036-09-23","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001484729-26-000006","document":"form4-09282026_080938.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000148472926000006/form4-09282026_080938.xml","form_type":"4"}},{"id":678736,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Warrant","published_at":"2026-08-21T22:35:36.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":186729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to June 25, 2031; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to June 25, 2031; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."}],"balance_after":186729,"derivative":{"exercise_price":1,"exercise_date":"2026-08-19","expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":186729},"source":{"system":"sec-edgar","filing":"0001484729-26-000005","document":"form4-08212026_100832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000148472926000005/form4-08212026_100832.xml","form_type":"4"}},{"id":678735,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Warrant","published_at":"2026-08-21T22:35:36.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":186729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after August 19, 2026, and on or prior to the earlier of (i) December 25, 2027 and (ii) thirty (30) days following the Issuer's public disclosure of the clearance of its Investigational New Drug Application by the U.S. Food and Drug Administration for CM5480; provided, however, that the warrant may not be exercised if the aggregate number of shares of Common Stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation, not to exceed 19.99%."}],"balance_after":186729,"derivative":{"exercise_price":0.8033,"exercise_date":"2026-08-19","expiration_date":"2027-12-25","underlying":"Common Stock","underlying_shares":186729},"source":{"system":"sec-edgar","filing":"0001484729-26-000005","document":"form4-08212026_100832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000148472926000005/form4-08212026_100832.xml","form_type":"4"}},{"id":723951,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-29T12:45:05.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":186729,"price":0.8033,"value":149999.4057,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":317655,"source":{"system":"sec-edgar","filing":"0001484729-26-000004","document":"form4-06292026_080601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000148472926000004/form4-06292026_080601.xml","form_type":"4"}},{"id":813386,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-08T01:50:06.000Z","date":"2025-04-05","kind":"grant","planned":false,"acquired":true,"shares":148482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period, provided, however, that no shares shall vest until the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual \"evergreen\" provision."}],"balance_after":148482,"derivative":{"exercise_price":0.585,"expiration_date":"2036-04-04","underlying":"Common Stock","underlying_shares":148482},"source":{"system":"sec-edgar","filing":"0001484729-26-000002","document":"form4-04072026_090402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000148472926000002/form4-04072026_090402.xml","form_type":"4"}},{"id":1084003,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-07-21T18:02:43.000Z","date":"2025-07-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3.4,"value":3400.0,"ownership":{"direct":false,"nature":"By Scheibler-Leheny Family Living Trust"},"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001415889-25-020052","document":"form4-07212025_060739.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588925020052/form4-07212025_060739.xml","form_type":"4"}},{"id":1087342,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-07-16T01:29:14.000Z","date":"2025-07-14","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.47,"value":6175.0,"ownership":{"direct":false,"nature":"By Scheibler-Leheny Family Living Trust"},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001415889-25-019816","document":"form4-07162025_010710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588925019816/form4-07162025_010710.xml","form_type":"4"}},{"id":1101041,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-26T22:26:23.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":77625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of CalciMedica, Inc. (the \"Company\") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the \"Amended 2023 EIP\") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":77625,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":77625},"source":{"system":"sec-edgar","filing":"0001415889-25-018305","document":"form4-06262025_100619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588925018305/form4-06262025_100619.xml","form_type":"4"}},{"id":1165560,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-25T20:30:22.000Z","date":"2025-04-23","kind":"grant","planned":false,"acquired":true,"shares":285000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning March 26, 2025, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period."}],"balance_after":285000,"derivative":{"exercise_price":1.53,"expiration_date":"2035-04-22","underlying":"Common Stock","underlying_shares":285000},"source":{"system":"sec-edgar","filing":"0001415889-25-011358","document":"form4-04252025_080419.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588925011358/form4-04252025_080419.xml","form_type":"4"}},{"id":1378168,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-11-01T17:25:51.000Z","date":"2024-11-01","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.75,"value":75000.0,"ownership":{"direct":true},"balance_after":130926,"source":{"system":"sec-edgar","filing":"0001415889-24-025880","document":"form4-11012024_051148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588924025880/form4-11012024_051148.xml","form_type":"4"}},{"id":1420841,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-08-28T23:07:59.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest in equal monthly installments over a four year period following March 28, 2024."}],"balance_after":115000,"derivative":{"exercise_price":4.16,"expiration_date":"2034-08-26","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001415889-24-022500","document":"form4-08282024_110856.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588924022500/form4-08282024_110856.xml","form_type":"4"}},{"id":1421890,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-08-27T23:44:47.000Z","date":"2024-08-27","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":4.1898,"value":4189.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $4.1898, and the range of prices were between $4.20 and $4.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":110926,"source":{"system":"sec-edgar","filing":"0001415889-24-022361","document":"form4-08272024_110843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588924022361/form4-08272024_110843.xml","form_type":"4"}},{"id":1537559,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-04-23T01:33:46.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant."}],"balance_after":115000,"derivative":{"exercise_price":4.16,"expiration_date":"2034-03-27","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001415889-24-011343","document":"form4-04232024_010439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588924011343/form4-04232024_010439.xml","form_type":"4"}},{"id":1670886,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Warrant","published_at":"2024-01-26T01:00:25.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":45543,"price":0.125,"value":5692.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."}],"balance_after":45543,"derivative":{"exercise_price":7.15,"exercise_date":"2024-01-23","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":45543},"source":{"system":"sec-edgar","filing":"0001415889-24-001828","document":"form4-01252024_080101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588924001828/form4-01252024_080101.xml","form_type":"4"}},{"id":1670885,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Warrant","published_at":"2024-01-26T01:00:25.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":45543,"price":0.125,"value":5692.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."}],"balance_after":45543,"derivative":{"exercise_price":5.36,"exercise_date":"2024-01-23","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":45543},"source":{"system":"sec-edgar","filing":"0001415889-24-001828","document":"form4-01252024_080101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588924001828/form4-01252024_080101.xml","form_type":"4"}},{"id":1670884,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-01-26T01:00:25.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":91086,"price":4.2665,"value":388618.419,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":109926,"source":{"system":"sec-edgar","filing":"0001415889-24-001828","document":"form4-01252024_080101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000141588924001828/form4-01252024_080101.xml","form_type":"4"}},{"id":1746737,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-09T01:42:38.000Z","date":"2023-11-07","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.34,"value":6680.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $3.34, and the range of prices were between $3.30 and $3.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":18840,"source":{"system":"sec-edgar","filing":"0001209191-23-054770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123054770/doc4.xml","form_type":"4"}},{"id":1747640,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-07T23:09:51.000Z","date":"2023-11-06","kind":"purchase","planned":false,"acquired":true,"shares":2440,"price":3.1208,"value":7614.752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $3.1208, and the range of prices were between $3.11 and $3.17. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":16840,"source":{"system":"sec-edgar","filing":"0001209191-23-054633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123054633/doc4.xml","form_type":"4"}},{"id":1748582,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-06T23:39:50.000Z","date":"2023-11-03","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.85,"value":14250.0,"ownership":{"direct":true},"balance_after":14400,"source":{"system":"sec-edgar","filing":"0001209191-23-054577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123054577/doc4.xml","form_type":"4"}},{"id":1854251,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-15T23:51:36.000Z","date":"2023-06-08","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":5.225,"value":5225.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $5.225, and the range of prices were between $5.20 and $5.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-23-037586","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123037586/doc4a.xml","form_type":"4/A","original_submission_date":"2023-06-09"}},{"id":1860440,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-10T01:16:39.000Z","date":"2023-06-09","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":5.25,"value":2100.0,"ownership":{"direct":true},"balance_after":9328,"source":{"system":"sec-edgar","filing":"0001209191-23-036127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123036127/doc4.xml","form_type":"4"}},{"id":1860439,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-10T01:16:39.000Z","date":"2023-06-08","kind":"purchase","planned":false,"acquired":true,"shares":928,"price":5.2269,"value":4850.5632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $5.2269, and the range of prices were between $5.20 and $5.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":8928,"source":{"system":"sec-edgar","filing":"0001209191-23-036127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123036127/doc4.xml","form_type":"4"}},{"id":1862188,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-09T01:09:38.000Z","date":"2023-06-07","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":5.2478,"value":5247.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction reported was $5.2478, and the range of prices were between $5.225 and $5.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-23-035609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123035609/doc4.xml","form_type":"4"}},{"id":1862187,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-09T01:09:38.000Z","date":"2023-06-06","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":5.1287,"value":5128.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $5.1287, and the range of prices were between $4.48 and $5.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001209191-23-035609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123035609/doc4.xml","form_type":"4"}},{"id":1866982,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-05T23:25:27.000Z","date":"2023-06-02","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":4.8,"value":4800.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-23-034646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123034646/doc4.xml","form_type":"4"}},{"id":1866981,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-05T23:23:37.000Z","date":"2023-05-16","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.698,"value":2698.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $2.698, and the range of prices were between $2.68 and $2.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-23-034642","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123034642/doc4a.xml","form_type":"4/A","original_submission_date":"2023-05-18"}},{"id":1871862,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-01T23:49:10.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":4.21,"value":4210.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $4.21, and the range of prices were between $4.00 and $4.48. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-23-033461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123033461/doc4.xml","form_type":"4"}},{"id":1879678,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-25T00:15:21.000Z","date":"2023-05-23","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":3.3439,"value":10031.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $3.3439, and the range of prices were between $3.09 and $3.37. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-23-032024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123032024/doc4.xml","form_type":"4"}},{"id":1886826,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-18T22:03:31.000Z","date":"2023-05-16","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.69,"value":2690.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-23-030778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123030778/doc4.xml","form_type":"4"}},{"id":1898105,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-05-10T22:16:52.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":110380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant."}],"balance_after":110380,"derivative":{"exercise_price":3.25,"expiration_date":"2033-05-07","underlying":"Common Stock","underlying_shares":110380},"source":{"system":"sec-edgar","filing":"0001209191-23-028546","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123028546/doc4.xml","form_type":"4"}},{"id":1941634,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":9935,"ownership":{"direct":false,"nature":"By Valence Investments SPV V, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F22","text":"Received in exchange for a stock option to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC (\"Valence IV\"), Valence Investments SPV V, LLC (\"Valence V\") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the \"Valence Securities\").  The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein."}],"balance_after":9935,"derivative":{"exercise_price":27.94,"expiration_date":"2026-05-25","underlying":"Common Stock","underlying_shares":9935},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941633,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":9935,"ownership":{"direct":false,"nature":"By Valence Investments SPV V, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F22","text":"Received in exchange for a stock option to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC (\"Valence IV\"), Valence Investments SPV V, LLC (\"Valence V\") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the \"Valence Securities\").  The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein."}],"balance_after":9935,"derivative":{"exercise_price":27.94,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":9935},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941632,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":12342,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"Received in exchange for a stock option to acquire 428,566 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"Beginning on November 22, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments."}],"balance_after":12342,"derivative":{"exercise_price":17.34,"expiration_date":"2023-03-19","underlying":"Common Stock","underlying_shares":12342},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941631,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":30443,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"Received in exchange for a stock option to acquire 1,057,071 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"Beginning on November 22, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments."}],"balance_after":30443,"derivative":{"exercise_price":17.34,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":30443},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941630,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":1717,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Received in exchange for a stock option to acquire 59,641 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"Beginning on November 22, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments."}],"balance_after":1717,"derivative":{"exercise_price":17.34,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":1717},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941629,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":1062,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Received in exchange for a stock option to acquire 36,905 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Immediately exercisable."}],"balance_after":1062,"derivative":{"exercise_price":10.42,"expiration_date":"2032-08-30","underlying":"Common Stock","underlying_shares":1062},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941628,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":2030,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Received in exchange for a stock option to acquire 70,490 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Immediately exercisable."}],"balance_after":2030,"derivative":{"exercise_price":10.42,"expiration_date":"2032-08-30","underlying":"Common Stock","underlying_shares":2030},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941627,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":3552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Received in exchange for a stock option to acquire 123,357 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Immediately exercisable."}],"balance_after":3552,"derivative":{"exercise_price":10.42,"expiration_date":"2032-08-30","underlying":"Common Stock","underlying_shares":3552},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941626,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":13964,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Received in exchange for a stock option to acquire 484,863 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Beginning on February 22, 2021, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments."}],"balance_after":13964,"derivative":{"exercise_price":7.99,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":13964},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941625,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":19826,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Received in exchange for a stock option to acquire 688,404 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Immediately exercisable."}],"balance_after":19826,"derivative":{"exercise_price":7.99,"expiration_date":"2031-04-27","underlying":"Common Stock","underlying_shares":19826},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941624,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":13964,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Received in exchange for a stock option to acquire 484,863 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Beginning on February 22, 2021, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments."}],"balance_after":13964,"derivative":{"exercise_price":7.99,"expiration_date":"2031-04-27","underlying":"Common Stock","underlying_shares":13964},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941623,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":30381,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Received in exchange for a stock option to acquire 1,054,921 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the shares subject to the option vested on June 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter."}],"balance_after":30381,"derivative":{"exercise_price":6.6,"expiration_date":"2030-06-29","underlying":"Common Stock","underlying_shares":30381},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941622,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":76173,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in exchange for a stock option to acquire 2,644,900 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on April 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter."}],"balance_after":76173,"derivative":{"exercise_price":6.6,"expiration_date":"2030-01-23","underlying":"Common Stock","underlying_shares":76173},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941621,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":11232,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in exchange for a stock option to acquire 390,000 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on April 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter."}],"balance_after":11232,"derivative":{"exercise_price":2.44,"expiration_date":"2029-04-24","underlying":"Common Stock","underlying_shares":11232},"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941620,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":316109,"ownership":{"direct":false,"nature":"By Valence Investments SPV VI, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in exchange for 10,975,977 shares of the common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC (\"Valence IV\"), Valence Investments SPV V, LLC (\"Valence V\") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the \"Valence Securities\").  The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein."}],"balance_after":316109,"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941619,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":66228,"ownership":{"direct":false,"nature":"By Valence Investments SPV V, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for 2,299,564 shares of the common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC (\"Valence IV\"), Valence Investments SPV V, LLC (\"Valence V\") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the \"Valence Securities\").  The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein."}],"balance_after":66228,"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}},{"id":1941618,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":20829,"kind":"person","name":"Leheny A. Rachel","position":1,"cik":"0001484729","reported_name":"Leheny A. Rachel","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-23T00:47:05.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":356989,"ownership":{"direct":false,"nature":"By Valence Investments SPV IV, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for an aggregate of 12,395,423 shares of common stock of CalciMedica, Inc. (\"CalciMedica\") pursuant to an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the \"Merger\"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC (\"Valence IV\"), Valence Investments SPV V, LLC (\"Valence V\") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the \"Valence Securities\").  The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein."}],"balance_after":356989,"source":{"system":"sec-edgar","filing":"0001209191-23-020676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484729/000120919123020676/doc4.xml","form_type":"4"}}]}